YUHSpace: Dept. of Internal Medicine (내과학교실)

YUHSpace

BROWSE

YUHSpace1. College of Medicine (의과대학)Dept. of Internal Medicine (내과학교실)

Dept. of Internal Medicine (내과학교실)

Researcher List

Keyword Cloud

Journal Categories

Highly Cited Articles

Trastuzumab in combination with chemotherapy versus chemotherapy alone f...

Yung-Jue Bang ; Eric Van Cutsem ; Andrea Feyereislova ; Hyun C Chung ; Lin Sh... LANCET, Vol.376(9742) : 687-697, 2010

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

Jean-Charles Soria ; Yuichiro Ohe ; Johan Vansteenkiste ; Thanyanan Reungwetw... NEW ENGLAND JOURNAL OF MEDICINE, Vol.378(2) : 113-125, 2018

Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer

S.J. Antonia ; A. Villegas ; D. Daniel ; D. Vicente ; S. Murakami ; R. Hui ; ... NEW ENGLAND JOURNAL OF MEDICINE, Vol.377(20) : 1919-1929, 2017

This table browses all dspace content
Issue Date	Title	Journal Title
2025	Zanidatamab monotherapy or combined with chemotherapy in HER2-expressing gastroesophageal adenocarcinoma: a phase 1 trial	NATURE COMMUNICATIONS
2025	Microarray Patch Based Transdermal Allergen Immunotherapy Prevents Gliadin-induced Anaphylaxis in a Murine Model	ALLERGY ASTHMA & IMMUNOLOGY RESEARCH
2025	Disagreement on estimating cause of death under tuberculosis treatment between the national tuberculosis registry and statistics data in South Korea, 2011-2020	JOURNAL OF INFECTION AND PUBLIC HEALTH
2025	Association of Extended Steroid Treatment With Bloodstream Infection in Critically Ill Patients With COVID-19: A National, Multicenter, Propensity Score-Matched Study	JOURNAL OF KOREAN MEDICAL SCIENCE
2025	Results from a phase Ib study of telisotuzumab vedotin in combination with osimertinib in patients with c-Met protein-overexpressing, EGFR-mutated locally advanced/metastatic non-small-cell lung cancer (NSCLC) after progression on prior osimertinib	ANNALS OF ONCOLOGY
2025	Predicting categories of coronary artery calcium scores from chest X-ray images using deep learning	JOURNAL OF CARDIOVASCULAR COMPUTED TOMOGRAPHY
2025	Application of an organoid-based model to explore Helicobacter pylori- human gastric epithelium interaction in vitro	FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
2025	Childhood trauma is associated with perceived stress and hair cortisol levels characterized by the BDNF Val66Met genotype and sex	FRONTIERS IN PSYCHIATRY
2025	Immunologic Response and Effects of COVID-19 Vaccines in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis	YONSEI MEDICAL JOURNAL
2025	Feasibility of percutaneous coronary intervention using a 7-French thin-walled sheath via the distal radial access	SCIENTIFIC REPORTS
2025	Deep learning-based identification of vertebral fracture and osteoporosis in lateral spine radiographs and DXA vertebral fracture assessment to predict incident fracture	JOURNAL OF BONE AND MINERAL RESEARCH
2025	Trends and management of acute respiratory failure in hospitalized patients: a multicenter retrospective study in South Korea	ACUTE AND CRITICAL CARE
2025	Plain language summary of first-line amivantamab-lazertinib in previously untreated high-risk EGFR-altered non-small-cell lung cancer in MARIPOSA	FUTURE ONCOLOGY
2025	Amivantamab Plus Lazertinib in Patients With EGFR-Mutant NSCLC After Progression on Osimertinib and Platinum-Based Chemotherapy: Results From CHRYSALIS-2 Cohort A	JOURNAL OF THORACIC ONCOLOGY
2025	First-Line Mobocertinib Versus Platinum-Based Chemotherapy in Patients With EGFR Exon 20 Insertion-Positive Metastatic Non-Small Cell Lung Cancer in the Phase III EXCLAIM-2 Trial	JOURNAL OF CLINICAL ONCOLOGY
2025	Methodology for the international working group clinical practice guidelines on X-linked hypophosphatemia in children and adults	JOURNAL OF BONE AND MINERAL METABOLISM
2025	Long-Term Hepatic and Extrahepatic Outcomes of Chronic Hepatitis C Patients After Sofosbuvir-Based Treatment (LONGHEAD Study)	INFECTIOUS DISEASES AND THERAPY
2025	Impact of Histology on Clinical Outcomes of Pembrolizumab Monotherapy in Patients With Advanced or Metastatic Urothelial Carcinoma in the Phase 3 KEYNOTE-045 and KEYNOTE-361 Trials	CLINICAL GENITOURINARY CANCER
2025	Osimertinib long-term tolerability in patients with EGFRm NSCLC enrolled in the AURA program or FLAURA study	LUNG CANCER
2025	A randomised non-comparative phase II study of atezolizumab, bevacizumab and chemotherapy in EGFR-mutant NSCLC with acquired resistance - The ETOP 15-19 ABC-lung trial	LUNG CANCER